Brenda Furlow

2020

In 2020, Brenda Furlow earned a total compensation of $1.8M as Executive Vice President and General Counsel at Bio-Techne, a 27% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$337,841
Option Awards$751,223
Salary$475,000
Stock Awards$251,195
Other$8,400
Total$1,823,659

Furlow received $751.2K in option awards, accounting for 41% of the total pay in 2020.

Furlow also received $337.8K in non-equity incentive plan, $475K in salary, $251.2K in stock awards and $8.4K in other compensation.

Rankings

In 2020, Brenda Furlow's compensation ranked 5,947th out of 13,090 executives tracked by ExecPay. In other words, Furlow earned more than 54.6% of executives.

ClassificationRankingPercentile
All
5,947
out of 13,090
55th
Division
Manufacturing
2,445
out of 5,617
57th
Major group
Chemicals And Allied Products
976
out of 2,248
57th
Industry group
Drugs
844
out of 1,948
57th
Industry
Biological Products, Except Diagnostic Substances
206
out of 411
50th
Source: SEC filing on September 14, 2022.

Furlow's colleagues

We found four more compensation records of executives who worked with Brenda Furlow at Bio-Techne in 2020.

2020

Charles Kummeth

Bio-Techne

Chief Executive Officer

2020

James Hippel

Bio-Techne

Chief Financial Officer

2020

David Eansor

Bio-Techne

Former President, Protein Sciences

2020

Kim Kelderman

Bio-Techne

President, Diagnostics and Genomics

News

You may also like